70
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Comparison of Outcomes and Prognostic Factors Between Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma Patients After Radical Surgery and Postoperative Adjuvant Radiotherapy

, ORCID Icon, ORCID Icon &
Pages 7597-7605 | Published online: 04 Oct 2021

References

  • Fujiwara K, Monk B, Devouassoux-Shisheboran M. Adenocarcinoma of the uterine cervix: why is it different? Curr Oncol Rep. 2014;16(12):416. doi:10.1007/s11912-014-0416-y25325935
  • Seoud M, Tjalma WA, Ronsse V. Cervical adenocarcinoma: moving towards better prevention. Vaccine. 2011;29(49):9148–9158. doi:10.1016/j.vaccine.2011.09.11521983356
  • Missaoui N, Trabelsi A, Landolsi H, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women. Asian Pac J Cancer Prev. 2010;11(3):777–780.21039053
  • Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer. 2004;100(5):1035–1044. doi:10.1002/cncr.2006414983500
  • Zhou J, Zhang WW, Wu SG, et al. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy. Int J Surg. 2017;44:1–6. doi:10.1016/j.ijsu.2017.05.07428583891
  • Shu T, Zhao D, Li B, et al. Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years’ experience of National Cancer Center in China. Chin J Cancer Res. 2017;29(6):510–520. doi:10.21147/j.issn.1000-9604.2017.06.0529353973
  • Huang YT, Wang CC, Tsai CS, et al. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;84(2):420–427. doi:10.1016/j.ijrobp.2011.12.01322365621
  • Lea JS, Coleman RL, Garner EO, et al. Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma. Gynecol Oncol. 2003;91(3):558–562. doi:10.1016/j.ygyno.2003.08.02014675676
  • Reis RD, Frumovitz M, Milam MR, et al. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007;107(3):458–463. doi:10.1016/j.ygyno.2007.07.08017854872
  • Zhang X, Lv Z, Xu X, et al. Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery. BMC Cancer. 2020;20(1):664. doi:10.1186/s12885-020-07148-x32678039
  • Song S, Song C, Kim HJ, et al. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy. Gynecol Oncol. 2012;124(1):63–67. doi:10.1016/j.ygyno.2011.09.03322004904
  • Cushman TR, Haque W, Menon H, et al. Postoperative chemoradiotherapy versus radiotherapy alone for elderly cervical cancer patients with positive margins, lymph nodes, or parametrial invasion. J Gynecol Oncol. 2018;29(6):e97. doi:10.3802/jgo.2018.29.e9730207105
  • Kim H, Park W, Kim YS, et al. Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor. J Gynecol Oncol. 2020;31(3):e35. doi:10.3802/jgo.2020.31.e3531912685
  • Zhou J, Wu SG, Sun JY, et al. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis. J Cancer Res Clin Oncol. 2017;143(1):115–122. doi:10.1007/s00432-016-2246-927646608
  • Yang K, Park W, Huh SJ, et al. Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer. Radiat Oncol J. 2017;35(1):39–47. doi:10.3857/roj.2016.0189327927011
  • Shimada M, Kigawa J, Nishimura R, et al. Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol. 2006;101(2):234–237. doi:10.1016/j.ygyno.2005.10.00416300819
  • Berek JS, Hacker NF, Fu YS, et al. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol. 1985;65(1):46–52.3966022
  • Drescher CW, Hopkins MP, Roberts JA. Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix. Gynecol Oncol. 1989;33(3):340–343. doi:10.1016/0090-8258(89)90524-62722061
  • Eifel PJ, Morris M, Oswald MJ, et al. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer. 1990;65(11):2507–2514. doi:10.1002/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO;2-92337867
  • Lee KB, Lee JM, Park CY, et al. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study. Int J Gynecol Cancer. 2006;16(4):1569–1573. doi:10.1111/j.1525-1438.2006.00628.x16884367
  • Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010;116(1):140–146. doi:10.1016/j.ygyno.2009.09.04019880165
  • Hu K, Wang W, Liu X, et al. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy. Radiat Oncol. 2018;13(1):249. doi:10.1186/s13014-018-1197-530558636
  • Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350(9077):535–540. doi:10.1016/S0140-6736(97)02250-29284774